Craigavon, United Kingdom

Eileen Parkes

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Almac Diagnostics Services Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eileen Parkes. Retrieved from https://idiyas.com/inventor/eileen-parkes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eileen Parkes: Innovator in Cancer Immunotherapy

Introduction

Eileen Parkes is a notable inventor based in Craigavon, GB. She has made significant contributions to the field of cancer immunotherapy, particularly through her innovative patent that addresses immune response subtypes associated with DNA damage. Her work aims to enhance the effectiveness of therapies for cancer patients.

Latest Patents

Eileen Parkes holds a patent titled "Gene signature for immune therapies in cancer." This patent describes a method for predicting responsiveness to antagonists of inhibitory immune checkpoints and agonists of stimulatory immune checkpoints. The method involves determining the expression level of specific genes in a sample from the subject, which can help stratify patients for particular therapies, including immune therapies combined with DNA damage therapeutics. She has 1 patent to her name.

Career Highlights

Throughout her career, Eileen has worked with prominent organizations, including Almac Diagnostics Services Limited and Almac Diagnostic Services Limited. Her expertise in the field has allowed her to contribute to advancements in cancer treatment and patient care.

Collaborations

Eileen has collaborated with notable professionals in her field, including Denis Paul Harkin and Timothy Davison. These partnerships have furthered her research and development efforts in cancer immunotherapy.

Conclusion

Eileen Parkes is a pioneering inventor whose work in cancer immunotherapy has the potential to transform treatment approaches for patients. Her innovative patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…